A Phase Ia clinical trial of IB-657 in hepatitis C-infected patients
Latest Information Update: 20 Jun 2016
Price :
$35 *
At a glance
- Drugs CB 183872 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 20 Jun 2016 New trial record
Latest Information Update: 20 Jun 2016